Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,982 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Estimation of post-therapeutic liver reserve capacity using 99mTc-GSA scintigraphy prior to carbon-ion radiotherapy for liver tumors.
Yamazaki K, Nishii R, Mizutani Y, Makishima H, Kaneko T, Isobe Y, Terada T, Tamura K, Imabayashi E, Tani T, Kobayashi M, Wakatsuki M, Tsuji H, Higashi T. Yamazaki K, et al. Among authors: tsuji h. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):581-592. doi: 10.1007/s00259-022-05985-5. Epub 2022 Oct 4. Eur J Nucl Med Mol Imaging. 2023. PMID: 36192469
Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study.
Ishikawa H, Tsuji H, Kamada T, Yanagi T, Mizoe JE, Kanai T, Morita S, Wakatsuki M, Shimazaki J, Tsujii H; Working Group for Genitourinary Tumors. Ishikawa H, et al. Among authors: tsuji h. Radiother Oncol. 2006 Oct;81(1):57-64. doi: 10.1016/j.radonc.2006.08.015. Epub 2006 Sep 12. Radiother Oncol. 2006. PMID: 16971008 Clinical Trial.
Quality of life in men treated with carbon ion therapy for prostate cancer.
Wakatsuki M, Tsuji H, Ishikawa H, Yanagi T, Kamada T, Nakano T, Suzuki H, Akakura K, Shimazaki J, Tsujii H. Wakatsuki M, et al. Among authors: tsuji h. Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1010-5. doi: 10.1016/j.ijrobp.2008.02.035. Epub 2008 May 19. Int J Radiat Oncol Biol Phys. 2008. PMID: 18495370 Clinical Trial.
Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
Kasuya G, Ishikawa H, Tsuji H, Nomiya T, Makishima H, Kamada T, Akakura K, Suzuki H, Shimazaki J, Haruyama Y, Kobashi G, Tsujii H; Working Group for Genitourinary Tumors. Kasuya G, et al. Among authors: tsuji h. Cancer. 2016 Oct 15;122(20):3225-3231. doi: 10.1002/cncr.30050. Epub 2016 Jun 28. Cancer. 2016. PMID: 27351298 Free PMC article. Clinical Trial.
Carbon-Ion Radiation Therapy for Pelvic Recurrence of Rectal Cancer.
Yamada S, Kamada T, Ebner DK, Shinoto M, Terashima K, Isozaki Y, Yasuda S, Makishima H, Tsuji H, Tsujii H, Isozaki T, Endo S, Takahashi K, Sekimoto M, Saito N, Matsubara H; Working Group on Locally Recurrent Rectal Cancer. Yamada S, et al. Among authors: tsuji h. Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):93-101. doi: 10.1016/j.ijrobp.2016.04.022. Epub 2016 Apr 23. Int J Radiat Oncol Biol Phys. 2016. PMID: 27375166 Clinical Trial.
Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer.
Maruyama K, Tsuji H, Nomiya T, Katoh H, Ishikawa H, Kamada T, Wakatsuki M, Akakura K, Shimazaki J, Aoyama H, Tsujii H; Working Group for Genitourinary Tumors. Maruyama K, et al. Among authors: tsuji h. J Radiat Res. 2017 Mar 1;58(2):260-266. doi: 10.1093/jrr/rrw122. J Radiat Res. 2017. PMID: 28043947 Free PMC article.
Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials.
Kasuya G, Kato H, Yasuda S, Tsuji H, Yamada S, Haruyama Y, Kobashi G, Ebner DK, Okada NN, Makishima H, Miyazaki M, Kamada T, Tsujii H; Liver Cancer Working Group. Kasuya G, et al. Among authors: tsuji h. Cancer. 2017 Oct 15;123(20):3955-3965. doi: 10.1002/cncr.30816. Epub 2017 Jun 29. Cancer. 2017. PMID: 28662297 Free PMC article. Clinical Trial.
Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.
Kasuya G, Ishikawa H, Tsuji H, Haruyama Y, Kobashi G, Ebner DK, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Makishima H, Nomiya T, Kamada T, Tsujii H; Working Group for Genitourinary Tumors. Kasuya G, et al. Among authors: tsuji h. Cancer Sci. 2017 Dec;108(12):2422-2429. doi: 10.1111/cas.13402. Epub 2017 Nov 3. Cancer Sci. 2017. PMID: 28921785 Free PMC article.
Carbon-ion radiotherapy for inoperable endometrial carcinoma.
Irie D, Okonogi N, Wakatsuki M, Kato S, Ohno T, Karasawa K, Kiyohara H, Kobayashi D, Tsuji H, Nakano T, Kamada T, Shozu M; and The Working Group of the Gynecological Tumor. Irie D, et al. Among authors: tsuji h. J Radiat Res. 2018 May 1;59(3):309-315. doi: 10.1093/jrr/rry003. J Radiat Res. 2018. PMID: 29528414 Free PMC article.
1,982 results